Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP339556.RATV5TJs0GsEdf_2oudmRgXM5HK6rdGaRKFmrVcCR_lI0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP339556.RATV5TJs0GsEdf_2oudmRgXM5HK6rdGaRKFmrVcCR_lI0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP339556.RATV5TJs0GsEdf_2oudmRgXM5HK6rdGaRKFmrVcCR_lI0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP339556.RATV5TJs0GsEdf_2oudmRgXM5HK6rdGaRKFmrVcCR_lI0130_provenance.
- NP339556.RATV5TJs0GsEdf_2oudmRgXM5HK6rdGaRKFmrVcCR_lI0130_assertion description "[Methylation frequencies of the genes tested in bladder cancers were 36% for CDH1, 35% for RASSF1A and APC, 29% for CDH13, 16% for FHIT, 15% for RAR beta, 11% for GSTP1, 7% for p16(INK4A), 4% for DAPK, and 2% for MGMT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP339556.RATV5TJs0GsEdf_2oudmRgXM5HK6rdGaRKFmrVcCR_lI0130_provenance.
- NP339556.RATV5TJs0GsEdf_2oudmRgXM5HK6rdGaRKFmrVcCR_lI0130_assertion evidence source_evidence_literature NP339556.RATV5TJs0GsEdf_2oudmRgXM5HK6rdGaRKFmrVcCR_lI0130_provenance.
- NP339556.RATV5TJs0GsEdf_2oudmRgXM5HK6rdGaRKFmrVcCR_lI0130_assertion SIO_000772 11751381 NP339556.RATV5TJs0GsEdf_2oudmRgXM5HK6rdGaRKFmrVcCR_lI0130_provenance.
- NP339556.RATV5TJs0GsEdf_2oudmRgXM5HK6rdGaRKFmrVcCR_lI0130_assertion wasDerivedFrom befree-2016 NP339556.RATV5TJs0GsEdf_2oudmRgXM5HK6rdGaRKFmrVcCR_lI0130_provenance.
- NP339556.RATV5TJs0GsEdf_2oudmRgXM5HK6rdGaRKFmrVcCR_lI0130_assertion wasGeneratedBy ECO_0000203 NP339556.RATV5TJs0GsEdf_2oudmRgXM5HK6rdGaRKFmrVcCR_lI0130_provenance.
- befree-2016 importedOn "2016-02-19" NP339556.RATV5TJs0GsEdf_2oudmRgXM5HK6rdGaRKFmrVcCR_lI0130_provenance.